Baeten, D.(Dominique Baeten)
disease patient treatment trial ef ﬁcacy sarcoidosi uveiti rheum tnf blockade therapy study arthritis ﬁcacy condition ﬂammatory blockade evidence beh çet disease medicine randomised pathway organ ﬂammation ﬂammatory diseases ophthalmol rheumatol outcome novel etanercept imatinib mesylate tnf blockers tumour necrosis factor ﬂiximab ﬁkakis pp effect case series evidence-based medicine placebo baughman review series blocker tnf receptor etanercept involvement number evidence-based example imatinib rheumatology concept ard.bmj.com mesylate case reports randomised placebo syndrome cost-ef ﬁcacy downloaded issue safety immune-mediated reference disorder side effects group.bmj.com ﬁ brosis factor bene ﬁt incidence brosi morbidity table lancet design =10 =13 practice group autoin necrosis organ involvement
1 Most Recent Publications
Use of TNF blockers and other targeted therapies in rare refractory immune-mediated inflammatory diseases: Evidence-based or rational?
Baeten, D. Hagen, P.M. van